Radiation Oncology/Treatment time

From Wikibooks, open books for an open world
Jump to navigation Jump to search

This page discusses how the time from surgery, overall treatment time, and time to deliver a fraction have an impact on the success of treatment.

See also: the appropriate Radiobiology concepts.

The concept of surgery to radiotherapy interval (SRI):

The concept of overall treatment time:

  • cervical cancer

Head & Neck[edit | edit source]

  • Aarhus, 2007 (Denmark) PMID 17493700 -- "Tumor progression in waiting time for radiotherapy in head and neck cancer." (Jensen AR, Radiother Oncol. 2007 Jul;84(1):5-10.)
    • Retrospective. 61 patients with SCCHN, with diagnostic and treatment-planning CT scan. Median interval between scans 28 days (5-95)
    • Outcome: 62% patients measurable increase in tumor volume; median increase 46% (6-495%). 20% new LN mets, 16% progression in T-stage
    • Doubling time: median 99 days, but median for faster half was 30 days.
    • Conclusion: Negative impact of waiting time; majority showed progression within 4 week waiting time
    • Editorial PMID 17574695 -- "Killing time: The consequences of delays in radiotherapy." (Mackillop WJ, Radiother Oncol. 2007 Jul;84(1):1-4.)
  • Wisconsin; 2007 PMID 17305251 -- "Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling." (Fowler JF, Clin Oncol (R Coll Radiol). 2007 Feb;19(1):8-22.)
    • LQ modelling for various schedules, calculated tumor log cell kill, with acute and late complications
    • Conclusion: Schedules of 4-6 weeks give 11 log10 cell kill; most require two fractions/day
  • Ontario, 1996 PMID 12118558 -- "The effect of delay in treatment on local control by radiotherapy." (Mackillop WJ, Int J Radiat Oncol Biol Phys. 1996 Jan 1;34(1):243-50.)
    • Monte Carlo simulation, applied to tonsillar CA
    • Outcome: at some point for every patient, probability of local control decreases sharply over a relatively short time period. LC rate decreases by ~10% per month for tonsillar CA
    • Conclusion: Waiting times for RT should be As Short As Reasonably Achievable (ASARA)

NSCLC[edit | edit source]

  • Netherlands; 2003 PMID 14676792 -- "Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy." (El Sharouni SY, Br J Cancer. 2003 Dec 15;89(12):2184-9.)
    • Retrospective. 23 patients with NSCLC. Interval times between end of induction of start of RT evaluated. Mean time to RT 80 days
    • Outcome: 41% potentially curable patients became incurable; tumor median doubling 29 days (8.3-171 days)
    • Conclusion: Accelerated tumor cell proliferation, much shorter doubling time than for untreated tumors. Gain from chemo (tumor decrease) was lost with waiting for RT